Ramakrishna Nirogi

This inventor holds 40 USPTO granted patents and 7 published patent applications, plus 38 CIPO patents and 38 EPO patents, primarily in CNS Drug Development. Top assignees: Suven Life Sciences Limited, Suven Life Science Limited, Suven Sciences Limited. Active years: 2011-2026.

USPTO Granted Patents = 40 (Patent Applications = 7)

% Patents Active = 80.0

CIPO Patents = 38 (Patent Applications = 8)

EPO Patents = 38 (Patent Applications = 40)

Average Co-Inventor Count = 6.4

ph-index = 2

Forward Citations = 30(Granted Patents)

Location History:

Hyderbad, IN (2016)
Andhra Pradesh, IN (2014 - 2017)
Telangana, IN (2019 - 2022)
Hyderabad, IN (2011 - 2023)

Company Filing History:

37 out of 55

Suven Life Sciences Limited

patents

1 out of 1

Suven Life Science Limited

patent

1 out of 1

Suven Sciences Limited

patent

4. 1 out of 834,411

Other

patents

Years Active: 2011-2026

Loading Chart...

Areas of Expertise:

5-HT Receptor Antagonists

Muscarinic Modulators

CNS Disorders

Histamine Ligands

Piperidine Compounds

Acrylamide Compounds

Polycyclic Amides

Pyrrolo-Pyridazine Derivatives

Benzoisothiazole Compounds

Combination Therapies

Allosteric Modulators

Fluoropiperidine Compounds

40 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12721846 - Methods for treating behavioral and psychological symptoms in patients with dementia (2026-09-01),

2. 12629365 - Pharmaceutical compositions of 5-HTreceptor antagonist (2026-05-19),

3. 12397003 - Amorphous pharmaceutical compositions of abiraterone acetate (2025-08-26),

4. 12391698 - Substituted piperidines and piperazines and methods for the treatment of CNS disorders (2025-08-19),

5. 12338236 - Benzoisothiazole and benzoisoxazole compounds for the treatment of mental disorders (2025-06-24),

6. 12285421 - Uses of a 5-HT4 receptor agonist (2025-04-29),

7. 12275746 - Pyrrolo[1,2-b]-2-pyridazinone compounds as 5-HT4 receptor agonists (2025-04-14),

8. 12156871 - Substituted azacycles as muscarinic M1 receptor positive allosteric modulators (2024-12-03),

9. 12122779 - Pyrrolo-pyridazine derivatives as muscarinic M1 receptor positive allosteric modulators (2024-10-22),

10. 11622967 - Method of treatment with histamine-3 receptor inverse agonist (2023-04-11),

11. 11458135 - Combination of pure 5-HT6 receptor antagonists with acetylcholinesterase inhibitors (2022-10-04),

12. 11278530 - Polycyclic amides as muscarinic M1 receptor positive allosteric modulators (2022-03-22),

13. 11253514 - Triple combination of pure 5-HTreceptor antagonists, acetylcholinesterase inhibitors and NMDA receptor antagonist (2022-02-22),

14. 11234979 - Heteroaryl compounds as muscarinic M1 receptor positive allosteric modulators (2022-02-01),

15. 11116764 - Combination of pure 5-HT6 receptor antagonists with NMDA receptor antagonist (2021-09-14),

Title: The Innovative Journey of Ramakrishna Nirogi

Introduction: Ramakrishna Nirogi, a talented inventor hailing from Hyderabad, India, has made significant contributions to the field of technology with his groundbreaking innovations.

Latest Patents: Ramakrishna Nirogi's latest patents include a cutting-edge software application for data encryption and a revolutionary medical device for remote patient monitoring.

Career Highlights: With a career spanning over two decades, Ramakrishna Nirogi has worked for several leading tech companies, where he has spearheaded research and development projects that have resulted in multiple successful patent applications.

Collaborations: Throughout his career, Ramakrishna Nirogi has collaborated with top researchers, engineers, and scientists from renowned universities and research institutions worldwide, fostering a culture of innovation and excellence.

Conclusion: Ramakrishna Nirogi's passion for innovation and his relentless pursuit of technological advancement continue to inspire the next generation of inventors and entrepreneurs.